Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies.
about
Functional effects of Toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cellsThe association between polymorphisms in the MRPL4 and TNF-α genes and susceptibility to allergic rhinitis.Hypersensitivity to aeroallergens in patients with nasobronchial allergyDiminished levels of nasal S100A7 (psoriasin) in seasonal allergic rhinitis: an effect mediated by Th2 cytokinesOptimal management of allergic rhinitis.Placebo-controlled study with OHIO chamber of prophylactic pranlukast for children with Japanese cedar pollinosis: TOPIC-J III study.The link between allergic rhinitis and asthma: the united airways disease.Pathophysiology, favoring factors, and associated disorders in otorhinosinusology.Preventing progression of allergic rhinitis to asthma.Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper.Rhinitis in children: common clinical presentations and differential diagnoses.The clinical significance of the pollen calendar of the Western Thrace/northeast Greece region in allergic rhinitis.Local expression of interleukin-17a is correlated with nasal eosinophilia and clinical severity in allergic rhinitis.Long-term intense exposure to grass pollen can mask positive effects of allergenic immunotherapy on non-specific bronchial hyperresponsiveness.HMGB1 in the Pathogenesis of Nasal Inflammatory Diseases and its Inhibition as New Therapeutic Approach: A Review from the Literature.A randomized controlled trial to assess adherence to allergic rhinitis treatment following a daily short message service (SMS) via the mobile phone.Characteristics of lower airway inflammatory changes in the minimal persistent inflammation of allergic rhinitis in mice.Tear film function in patients with seasonal allergic conjunctivitis outside the pollen season.Azelastine enhances the clinical efficacy of glucocorticoid by modulating MKP-1 expression in allergic rhinitis.Cysteinyl leukotriene levels correlate with 8-isoprostane levels in exhaled breath condensates of atopic and healthy children.Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-κB in allergic rhinitis patients.Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis.The impact of allergen exposure and specific immunotherapy on circulating blood cells in allergic rhinitis
P2860
Q33699965-E3A504E7-99BC-41E1-ABFE-51DC223A9A07Q34614592-D5FFD727-F709-45FC-8D6A-17621A8ACBD3Q34746348-DF7D5AE0-434D-47AC-9095-F9310FB44C23Q35780340-AA73BECF-380E-4AB2-BD40-0DCAA4737F35Q35888881-C8805787-F277-4C94-9C4E-7CAB9A596313Q37077134-5AB362E3-546C-4CEE-B9D0-BFF97E2C0AFDQ37742100-7E56E9E3-C965-4F84-AB8C-30B6FA7C81F8Q38023963-9B5994F9-E71E-4AD8-8887-CF84894F2A35Q38177218-480C07C1-5D01-4FDA-8219-7399CA4F8D23Q38206795-91802E12-BBA8-431D-B682-C733798D6E3AQ38330274-9000A816-270D-434A-AA85-A28CE803B8F6Q38413189-48C8495C-B0C1-4865-8C39-1CBD152B75B0Q39570009-D5F6EB8C-13C2-4F2A-8AA4-7B2922D8400DQ41718803-0C2847E8-4B10-4B75-B5E8-130618AD6A3EQ42277659-53DC5BF7-9389-48A9-ABD6-5606B1827544Q43488106-9965DBD9-4FC0-42B8-A221-B1CAD0774C79Q47560058-61BD275B-6DB1-4B52-9257-85394E7F9802Q51414561-51980C4C-14CF-47A6-BDB7-C833BB1F26C5Q54335183-B9E5FB3E-B657-48F9-ACA8-F9FB59F12998Q54705677-AAFE964B-E8BD-4DAD-AE96-3BF38D513CEAQ55345249-5351EBF3-8000-4D62-8C7C-49CB519C2A1FQ55403212-2E56B046-56C4-44DC-9FEF-ABA0EF49EEECQ58611597-1A3FC69F-8067-497E-91DC-0ABB46052743
P2860
Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Minimal persistent inflammatio ...... current treatment strategies.
@en
Minimal persistent inflammatio ...... current treatment strategies.
@nl
type
label
Minimal persistent inflammatio ...... current treatment strategies.
@en
Minimal persistent inflammatio ...... current treatment strategies.
@nl
prefLabel
Minimal persistent inflammatio ...... current treatment strategies.
@en
Minimal persistent inflammatio ...... current treatment strategies.
@nl
P2860
P1476
Minimal persistent inflammatio ...... current treatment strategies.
@en
P2093
E Compalati
P2860
P304
P356
10.1111/J.1365-2249.2009.04017.X
P577
2009-08-25T00:00:00Z